换一批
换一批Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group.
作者：
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);人类(Humans);干扰素α(Interferon-alpha);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);中年人(Middle Aged);肿瘤, 残余(Neoplasm, Residual);中性粒细胞减少(Neutropenia);重组蛋白质类(Recombinant Proteins);缓解诱导(Remission Induction);瑞典(Sweden);血小板减少(Thrombocytopenia)
DOI
10.1080/10428190701704647
PMID
18203019
发布时间
2021-01-03
- 浏览18
Leukemia & lymphoma
102-12页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
